Healthy Adult Male Clinical Trial
Official title:
Phase 1, Open-Label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Intravenous Dose of [14C]-VVZ-149 in Healthy Adult Male Subjects
This is an open-label, single-dose, absorption, metabolism, excretion, and mass balance study following a single IV infusion of [14C]-VVZ-149 in healthy adult male subjects. Whole blood, plasma, urine, and fecal samples will be analyzed for at least 72 hours following the start of infusion to measure total radioactivity and plasma drug concentrations.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02875080 -
Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT04182958 -
A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
|
Phase 1 | |
| Completed |
NCT03902574 -
Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg
|
Phase 1 | |
| Completed |
NCT05439148 -
OPC-61815 in Healthy Chinese Male Subjects
|
Phase 1 | |
| Completed |
NCT02994394 -
A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects
|
Phase 1 | |
| Completed |
NCT01423435 -
Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males
|
Phase 1 | |
| Completed |
NCT01258699 -
A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects
|
Phase 1 |